|
Fatty Acid Antiarrhythmia Trial (FAAT) Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Fatty Acid Antiarrhythmia Trial (FAAT) conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Fatty Acid Antiarrhythmia Trial (FAAT) Clinical research trials and Fatty Acid Antiarrhythmia Trial (FAAT) healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Fatty Acid Antiarrhythmia Trial (FAAT). Fatty Acid Antiarrhythmia Trial (FAAT) Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Fatty Acid Antiarrhythmia Trial (FAAT) clinical trial. Participants typically obtain the most effective healthcare available for their Fatty Acid Antiarrhythmia Trial (FAAT) condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "F" Clinical Trials Conditions > Fatty Acid Antiarrhythmia Trial (FAAT)  Fatty Acid Antiarrhythmia Trial (FAAT)
Fatty Acid Antiarrhythmia Trial (FAAT)
For Condition: Heart Diseases,Arrhythmia,Ventricular Fibrillation,Tachycardia, Ventricular
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine if the dietary N-3 class of polyunsaturated fatty acids (PUFAs) provided in the diet largely from marine fish oils will prevent fatal ventricular tachycardia (VT) or ventricular fibrillation (VF).
Details: BACKGROUND: Sudden death is a common manifestation of ischemic heart disease and therefore of great public health concern. Unfortunately several promising antiarrhythmic drugs proved not to be effective in preventing sudden deaths. This project would test whether a relatively inexpensive and presumably innocuous therapy, fish oil supplements, can prevent life-threatening arrhythmias. There is ample basic evidence that n-3 fatty acids contained in fish oil supplements may suppress arrhythmias, and a clinical trial seems warranted. DESIGN NARRATIVE: Prospective, randomized, placebo-controlled, double-blind. Patients were randomized to 4 grams per day of a PUFA fish oil supplement versus an olive oil placebo. The number of therapeutic discharges were recorded from the ICDs and then confirmed from the recorded electrocardiogram strips with the kinds of arrhythmias which had induced the ICD response. The primary endpont was the number of ICD discharges for fatal arrhythmias.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Massachusetts General Hospital
Boston, Massachusetts, 02114-2696
United States
Additional Information:
Study ID Numbers: 127;
Study Start Date: March 1999
Record last reviewed: October 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004559
Other Heart Diseases Studies:
1. Prognostic Significance of T Wave Alternans
2. Beta-Blocker Heart Attack Trial (BHAT)
3. Fatty Acid Antiarrhythmia Trial (FAAT)
4. Public Access Defibrillation (PAD) Community Trial
5. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
Related Studies:
Other Heart Diseases Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Fatty Acid Antiarrhythmia Trial (FAAT)
|
|
|
|
|
|
|
|
